Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis

Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis

Background: How the oncoprotein epidermal growth factor receptor (EGFR) evades proteolytic degradation and accumulates in non-small cell lung cancer (NSCLC) remains unclear, and ubiquitin pathway genes (UPGs) that are critical to NSCLC needs to be systematically identified. Methods: A total of 696 U...

Full description

Bibliographic Details
Main Authors:	Xin-Chun Zhao, Gui-Zhen Wang, Zhe-Sheng Wen, Yong-Chun Zhou, Qian Hu, Bin Zhang, Li-Wei Qu, San-Hui Gao, Jie Liu, Liang Ma, Yan-Fei Zhang, Chen Zhang, Hong Yu, Da-Lin Zhang, Min Wang, Chang-Li Wang, Yun-Chao Huang, Zhi-hua Liu, Yong Zhao, Liang Chen, Guang-Biao Zhou
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420300645

Similar Items

MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis
by: Ranakul Islam, et al.
Published: (2023-02-01)

Author Correction: The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy
by: Gui-Zhen Wang, et al.
Published: (2022-06-01)

Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy
by: Shizhen Zhang, et al.
Published: (2020-04-01)

Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration
by: Xiao Zhang, et al.
Published: (2020-08-01)

Vasculogenic mimicry in carcinogenesis and clinical applications
by: Qingxi Luo, et al.
Published: (2020-03-01)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
by: Feng Wang, et al.
Published: (2022-07-01)

Oral Bacteriome and Mycobiome across Stages of Oral Carcinogenesis
by: Weiwei Heng, et al.
Published: (2022-12-01)

CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation
by: Jian Huang, et al.
Published: (2022-07-01)

Erratum to: CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling
by: Dong-Fang Meng, et al.
Published: (2017-02-01)

A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer.
by: Yong Wang, et al.
Published: (2024-01-01)

Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy
by: Zhen Wang, et al.
Published: (2022-07-01)

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
by: Marco Macagno, et al.
Published: (2022-01-01)

Epigenetic Regulation in Chromium-, Nickel- and Cadmium-Induced Carcinogenesis
by: Lei Zhao, et al.
Published: (2022-11-01)

Comprehensive analysis of BTN3A1 in cancers: mining of omics data and validation in patient samples and cellular models
by: Fan Liang, et al.
Published: (2021-09-01)

Disorder of three‐dimensional chromosome structure plays a role in carcinogenesis
by: Linlin Zhang, et al.
Published: (2021-10-01)

Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.
by: Guiyang Jiang, et al.
Published: (2013-01-01)

Systematic analysis of concentrations of 52 elements in tumor and counterpart normal tissues of patients with non‐small cell lung cancer
by: Xin Cheng, et al.
Published: (2019-12-01)

Curative Effect of EGFR-TKIs with Anti-angiogenic Drugs as the Treatment for Patients with Advanced EGFR-mutant Non-small Cell Lung Cancer：a Meta-analysis
by: LI Yong, LONG Yong, ZHAO Chong, ZHANG Guanqing, SU Yanhe
Published: (2022-03-01)

Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates.
by: Norbury, C, et al.
Published: (1991)

Identification of Novel Mutations in CDC20: Expanding the Mutational Spectrum for Female Infertility
by: Lin Zhao, et al.
Published: (2021-04-01)

1-(3,4-Dichlorobenzyl)-3-methylquinolin-1-ium 7,7,8,8-tetracyanoquinodimethanide
by: Guang-Xiang Liu, et al.
Published: (2010-02-01)

S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness
by: Yanan Li, et al.
Published: (2020-01-01)

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
by: Mengmeng Niu, et al.
Published: (2021-10-01)

MicroRNA-34a promotes the senescence and apoptosis of human lens epithelial cells by up-regulating Cdc42 and Rac1
by: Wen Lan, et al.
Published: (2020-05-01)

Screening of differentially expressed transcription factors in keratinocytes with overexpression of EGFR induced by rhPTH(1-34)
by: Wenqi ZHAO, et al.
Published: (2023-08-01)

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
by: Wen M, et al.
Published: (2018-11-01)

IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis
by: Yuhang Zhou, et al.
Published: (2017-04-01)

Gefitinib analogue V1801 induces apoptosis of T790M EGFR-harboring lung cancer cells by up-regulation of the BH-3 only protein Noxa.
by: Bo Zhang, et al.
Published: (2012-01-01)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
by: Zhe Zhang, et al.
Published: (2019-11-01)

Isomaltooligosaccharides inhibit early colorectal carcinogenesis in a 1,2-dimethylhydrazine-induced rat model
by: Xiao Chen, et al.
Published: (2022-09-01)

Circular RNA profiles and the potential involvement of down‐expression of hsa_circ_0001360 in cutaneous squamous cell carcinogenesis
by: Pingjiao Chen, et al.
Published: (2021-04-01)

The Oncogenic Roles of JC Virus T Antigen in Breast Carcinogenesis
by: Hua-chuan Zheng, et al.
Published: (2021-08-01)

The role of phosphatidylcholine 34:1 in the occurrence, development and treatment of ulcerative colitis
by: Tengjie Yu, et al.
Published: (2023-03-01)

Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations
by: Chen Shi, et al.
Published: (2023-06-01)

Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy
by: Zhulin Wang, et al.
Published: (2024-03-01)

Targeting CD36 determines nicotine derivative NNK-induced lung adenocarcinoma carcinogenesis
by: Ming-Yue Li, et al.
Published: (2023-08-01)

SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer
by: Luwei Han, et al.
Published: (2021-04-01)

EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells
by: Yang Ruijie, et al.
Published: (2010-10-01)

Characterization and application of a lytic jumbo phage ZPAH34 against multidrug-resistant Aeromonas hydrophila
by: Yuting Hou, et al.
Published: (2023-06-01)

Cdc42 upregulation under high glucose induces podocyte apoptosis and impairs β-cell insulin secretion
by: Shan Jiang, et al.
Published: (2022-08-01)